- Rigel Pharmaceuticals (NASDAQ:RIGL): Q4 EPS of -$0.25 beats by $0.01.
- Revenue of $8.25M (+43.5% Y/Y) beats by $6.58M.
- Press Release
Rigel Pharmaceuticals beats by $0.01, beats on revenue
Recommended For You
More Trending News
About RIGL Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| RIGL | - | - |
| Rigel Pharmaceuticals, Inc. | ||